Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Precision and Ease-of-Use Characterize New Line of Microcentrifuges

By BiotechDaily International staff writers
Posted on 30 Jul 2013
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
A new line of microcentrifuges was designed to meet the specific requirements of a wide range of research applications while being efficient and easy to use.

The Beckman Coulter Life Sciences (Indianapolis, IN, USA) Microfuge 20 and 20R microcentrifuges are compact instruments that provide flexibility and reliable, precise performance whether in refrigerated (the Microfuge 20R) or nonrefrigerated (Microfuge 20) mode of operation. These microcentrifuges are intended for a wide range of biotech research applications including nucleic acid and protein preparation; pelleting, extractions, purifications, concentrations, phase separations and receptor binding; and rapid sedimentation of protein precipitates, particulates, and cell debris. An easy-to-use interface facilitates entry and recall of up to 10 user-defined programs.

Samples can be processed at speeds up to 15,000 rpm (20,627 x g) and the temperature in the Microfuge 20R can be adjusted over a range of -10 to +40 degrees Celsius. Fixed angle rotors are made of polypropylene or aluminum and offer capacities of 24 or 36 microcentrifuge tubes or four PCR tube strips.

“The Microfuge 20 series provides researchers with an accurate, reliable, and durable microcentrifuge,” said David Rolwing, centrifuge product manager at Beckman Coulter Life Sciences. “Strong performance and ergonomic features combine in these units to provide confidence and efficiency.”

Related Links:
Beckman Coulter Life Sciences




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.